Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity
Abstract Coxiella burnetii is the bacterial causative agent of the zoonosis Q fever. The current human Q fever vaccine, Q-VAX®, is a fixed, whole cell vaccine (WCV) licensed solely for use in Australia. C. burnetii WCV administration is associated with a dermal hypersensitivity reaction in people wi...
Main Authors: | Carrie M. Long, Paul A. Beare, Diane C. Cockrell, Jonathan Fintzi, Mahelat Tesfamariam, Carl I. Shaia, Robert A. Heinzen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00296-6 |
Similar Items
-
Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation.
by: Paul A Beare, et al.
Published: (2018-03-01) -
Comparative virulence of diverse Coxiella burnetii strains
by: Carrie M Long, et al.
Published: (2019-01-01) -
Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against Coxiella burnetii While Minimizing Reactogenic Responses
by: Alycia P. Fratzke, et al.
Published: (2021-03-01) -
A Coxiella burnetii phospholipase A homolog pldA is required for optimal growth in macrophages and developmental form lipid remodeling
by: Christopher M. Stead, et al.
Published: (2018-04-01) -
Coxiella burnetii Lipopolysaccharide: What Do We Know?
by: Prasad Abnave, et al.
Published: (2017-11-01)